Collegium Pharmaceutical
(NASDAQ:COLL)
Collegium Pharmaceutical, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Collegium Pharmaceutical, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$18.80
-0.40[-2.08%]
At close: Aug 12
$18.80
After Hours: 4:01PM EDT
Day High/Low18.77 - 19.44
52 Week High/Low14.04 - 22.89
Open / Close19.14 / 18.8
Float / Outstanding24.5M / 34.1M
Vol / Avg.174.7K / 300.8K
Mkt Cap641.6M
P/E-
50d Avg. Price17.45
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float24.5M

Collegium Pharmaceutical (NASDAQ:COLL), Quotes and News Summary

Collegium Pharmaceutical (NASDAQ: COLL)

Day High/Low18.77 - 19.44
52 Week High/Low14.04 - 22.89
Open / Close19.14 / 18.8
Float / Outstanding24.5M / 34.1M
Vol / Avg.174.7K / 300.8K
Mkt Cap641.6M
P/E-
50d Avg. Price17.45
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float24.5M
Sector: Health Care.Industry: Pharmaceuticals
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Collegium Pharmaceutical Questions & Answers

Q
How do I buy Collegium Pharmaceutical (COLL) stock?
A

You can purchase shares of Collegium Pharmaceutical (NASDAQ: COLL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Collegium Pharmaceutical's (COLL) competitors?
Q
What is the target price for Collegium Pharmaceutical (COLL) stock?
A

The latest price target for Collegium Pharmaceutical (NASDAQ: COLL) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting COLL to fall to within 12 months (a possible -78.72% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Collegium Pharmaceutical (COLL)?
A

The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $18.8 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Collegium Pharmaceutical (COLL) pay a dividend?
A

The next Collegium Pharmaceutical (COLL) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Collegium Pharmaceutical (NASDAQ:COLL) reporting earnings?
A

Collegium Pharmaceutical’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Collegium Pharmaceutical (COLL) going to split?
A

There is no upcoming split for Collegium Pharmaceutical.

Q
What sector and industry does Collegium Pharmaceutical (COLL) operate in?
A

Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.